
Infection and Immunotherapy Research Group
The goal of the Infection and Immunotherapy Research (IIR) is to develop new immunotherapies against infectious diseases and cancer. They aim to provide a new translational understanding on HIV cure, bacterial infections and of cancer immunology. The group is also involved in clinical research working towards the elimination of HIV and Hepatitis in Luxembourg.
Aims and objectives
We focus on the development of immunotherapeutic complexes and NK cell engagers boosting innate immunity against viruses, bacteria and cancer cells for further elimination by the immune system. Our research encompasses protein engineering, virology, bacteriology, immunoassays and preclinical studies for the design of targeted therapeutic approaches.
HIV and viral hepatitis elimination
Our group support the monitoring of HIV and Hepatitis elimination in Luxembourg, as part of international research and surveillance networks, through outreach projects and clinical studies from the national HIV and Hepatitis programmes.
Seguin-Devaux
Projects & clinical trials
Featured team members
Scientific publications
-
Co-occurrence of memory impairment and fatigue distinguishes post COVID from pandemic-related health effects in the 4-year CON-VINCE cohort study – 27/10/2025
-
Directed-complement killing of Pseudomonas aeruginosa protects against lethal pneumonia – 16/09/2025
-
Directed-Complement Activation as a Novel Immunotherapeutic Approach for HER2-Breast Cancer – 05/09/2025
-
Standardising monitoring data on drug-related infectious diseases among people who inject drugs in Europe – an update of the European Union Drugs Agency technical protocol, 2024 – 31/07/2025
-
Fighting Antibiotic Resistance – 27/03/2025
Related News

Job vacancies
There are no jobs matching this page at the moment. You can view all jobs via the button below.



